China rewrites its regulatory framework for stem cell clinical translation

Ruohan Feng, Xue Pang, Yi Hao, Tong Zhao, Yaojin Peng

Open source

DOI: 10.1016/j.stem.2026.09.017
Published: 2026-11
Container: Cell Stem Cell
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.stem.2026.09.017,
  title = {China rewrites its regulatory framework for stem cell clinical translation},
  author = {Ruohan Feng and Xue Pang and Yi Hao and Tong Zhao and Yaojin Peng},
  year = {2026},
  journal = {Cell Stem Cell},
  doi = {10.1016/j.stem.2026.09.017},
  url = {https://doi.org/10.1016/j.stem.2026.09.017}
}

RIS

TY  - JOUR
TI  - China rewrites its regulatory framework for stem cell clinical translation
AU  - Ruohan Feng
AU  - Xue Pang
AU  - Yi Hao
AU  - Tong Zhao
AU  - Yaojin Peng
PY  - 2026
JO  - Cell Stem Cell
DO  - 10.1016/j.stem.2026.09.017
UR  - https://doi.org/10.1016/j.stem.2026.09.017
ER  -

APA

Feng, R., Pang, X., Hao, Y., Zhao, T., & Peng, Y. (2026). China rewrites its regulatory framework for stem cell clinical translation. Cell Stem Cell. https://doi.org/10.1016/j.stem.2026.09.017

Source records

crossref · retrieved 2026-11-07T13:08:20.617Z